National Bank of Canada FI Raises Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

National Bank of Canada FI lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 15,986 shares of the exchange traded fund’s stock after buying an additional 1,589 shares during the quarter. National Bank of Canada FI’s holdings in SPDR S&P Biotech ETF were worth $1,579,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Fifth Third Bancorp raised its position in shares of SPDR S&P Biotech ETF by 3.4% during the 2nd quarter. Fifth Third Bancorp now owns 118,303 shares of the exchange traded fund’s stock worth $10,968,000 after acquiring an additional 3,922 shares in the last quarter. PFG Investments LLC raised its holdings in SPDR S&P Biotech ETF by 9.2% during the second quarter. PFG Investments LLC now owns 24,844 shares of the exchange traded fund’s stock worth $2,303,000 after purchasing an additional 2,097 shares in the last quarter. IFG Advisory LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $241,000. Beaton Management Co. Inc. acquired a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at $212,000. Finally, Atria Wealth Solutions Inc. grew its position in shares of SPDR S&P Biotech ETF by 56.1% in the 2nd quarter. Atria Wealth Solutions Inc. now owns 16,597 shares of the exchange traded fund’s stock valued at $1,539,000 after buying an additional 5,962 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $93.40 on Friday. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The firm has a market capitalization of $7.12 billion, a P/E ratio of 11.47 and a beta of 1.11. The company’s fifty day moving average price is $98.05 and its 200 day moving average price is $97.06.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.